Lepu Medical Technology (Beijing) Co., Ltd. Environmental Analytics
Environmental and financial analysis dashboard for Lepu Medical Technology (Beijing) Co., Ltd.. Industry: MANUFACTURING
Company Overview for Lepu Medical Technology (Beijing) Co., Ltd.
Highlights
Showing data for FY2022
Operational Environmental Cost
$4.06m
Operational Environmental Cost Intensity
0.27%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$1.14m
Decoupling Rate (2020-2022)
-5.87%
Adjusted EBITDA
$469m
Adjusted EBITDA Margin
31%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 37.95% | 5.22% | -11.96% | ||
| 0.18% | 0.18% | 0.21% | 0.25% | |
| 2.18% | 17.04% | -21.97% | ||
| 0.06% | 0.04% | 0.05% | 0.06% | |
| $3m | $4m | $4m | $3m | |
| 29.57% | 7.41% | -13.98% | ||
| 0.24% | 0.23% | 0.27% | 0.31% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
31%
Adjusted EBIT Margin
26%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$1,229m | $1,673m | $1,526m | $1,125m | |
| 36.07% | -8.75% | -26.27% | ||
$792m | $1,230m | $1,053m | $810m | |
| 64.42% | 73.51% | 69.00% | 71.95% | |
$437m | $443m | $473m | $316m | |
| 35.58% | 26.49% | 31.00% | 28.05% | |
$378m | $373m | $403m | $243m | |
| 30.75% | 22.28% | 26.40% | 21.62% | |
| ENVIRONMENTAL COST DATA | ||||
$3m | $4m | $4m | $3m | |
| 0.24% | 0.23% | 0.27% | 0.31% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$434m | $439m | $469m | $312m | |
| 35.35% | 26.26% | 30.73% | 27.74% | |
$375m | $369m | $399m | $240m | |
| 30.52% | 22.05% | 26.13% | 21.31% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF MEDICAL AND DENTAL INSTRUMENTS AND SUPPLIES
Scope 1 (% of Sales)
0.21%
Scope 2 (% of Sales)
0.05%
Operational Environmental Cost Intensity
0.27%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Lepu Medical Technology (Beijing) Co., Ltd. | N/A | $4m | 0.27% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $63m | 14.71% | N/A | N/A |
Energy-related activities (3) | $166m | 38.76% | N/A | N/A |
Upstream transportation (4) | $7m | 1.53% | N/A | N/A |
Waste (5) | $1m | 0.13% | N/A | N/A |
Business travel (6) | $1m | 0.13% | N/A | N/A |
Commuting (7) | $0m | 0.07% | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $5m | 1.11% | N/A | N/A |
Processing of products (10) | $0m | 0.00% | N/A | N/A |
Use of products (11) | $175m | 40.66% | N/A | N/A |
Final treatment of products (12) | $12m | 2.90% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $429m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022